OncoSec Announces Publication of New Research in the Journal Immunity Highlighting the Role of IL-12 in Anti-PD-1 Therapies with TAVO(TM) Directly Activating TILs in Patients
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.